Accel Wealth Management Xenon Pharmaceuticals Inc. Transaction History

Accel Wealth Management

  • $263 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$15.6 - $35.4 $60,840 - $138,060
-3,900 Closed
0 $0
Q3 2021

Nov 04, 2021
BUY
$14.86 - $19.45 $57,954 - $75,855
3,900 New
3,900 $60,000
Q1 2021

May 10, 2021
SELL
$13.65 - $21.31 $122,850 - $191,790
-9,000 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$9.49 - $16.04 $85,410 - $144,360
9,000 New
9,000 $138,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Accel Wealth Management Portfolio

Follow Accel Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Accel Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email